Abstract-The effect of agrimoniin, a tannin contained in Agrimonia pilosa LEDEB., on ascites type and solid type rodent tumors was investigated.
A number of plants containing tannins have been traditionally known to be effective against cancers and tumors. However, since the isolation of pure tannins from the plants has been difficult, we could not determine the characteristics and activities of each tannin until now. Agrimonia pilosa LEDEB. has been traditionally known as a plant with effective antitumor activity, and it is being used for cancer therapy in China today (1) . Recently, Okuda et al. (2) have isolated agrimoniin, a dimeric ellagitannin, from this plant, and we have indicated that this tannin is the main antitumor active constituent of this plant (3) .
The present study deals with the effect of agrimoniin on ascites and solid type mouse tumors.
Materials and Methods
Agents: Agrimoniin ( Fig. 1) was isolated by the method described in the previous paper (3) . OK-432 (Chugai), concanavalin A (Con A, Maruzen Oil), Escherichia co/i lipopoly saccharide (E. coli LPS, Wako Pure Chemical), 3H-thymidine (3H-Td R, New England Nuclear) were purchased from commercial sources. Agents were dissolved in physiological buffered saline (PBS) before use.
Animals and tumors: Six-weeks-old ddY, C3H/He and BALB/c mice were purchased from Shizuoka Laboratory Animal Center, Hamamatsu. MM2 mammary carcinoma and MH134 hepatoma were maintained by intra peritoneal (i.p.) passage at weekly intervals in female C3H mice. Meth-A fibrosarcoma was maintained in a similar manner in female BALB/c mice.
Acute toxicity on mice: Female and male ddY mice were i.p., intravenously (i. for 24 hr at 37°C. After the incubation, cells were harvested on a glass fiber filter (Whatman, GF/C) and washed with cold PBS, 5% trichloroacetic acid and an ethanol: ether (3:1, v/v) mixture. The radio activity on the filter was counted in a toluene based scintillator (4 g PPO, 0.1 g POPOP, 1 I toluene) by a Beckman LS-230 liquid scintillation counter.
3H-TdR uptake by spleen cells: The in vivo (i.p.) or in vitro stimulated cells (1 x 106) were cultured with 0.1 /1C1 3H-TdR for 24 hr and harvested on a glass filter, and the radio activity on the filter was counted by the method described above.
Results
Acute toxicity on mice: Most of the mice i.p. injected with over 10 mg/kg of agrimoniin developed stretching and writhing reactions within 5 min. Then, mice that received lethal doses fell in a depressed and bradypnic state and gradually died after myoclonus within 4 days. The remaining mice recovered to a normal state within 7 days after the adminis tration. In i.v. administration, the tail of the injection site developed cyanosis and necrosis. Symptoms were similar to those of the i.p. administration except for the stretching and writhing reactions, and the mice recovered to a normal state at an earlier time compared with the i.p. administration. Mice p.o. administered with 1000 mg/kg developed only a slight depressed state for about 2 hr. The LD50 values of agrimoniin are shown in Table 1 . There was no difference between the sexes in each administration route. Antitumor effect on M M2 ascites type tumor: As shown in Table 2 , when i.p. injected with a single dosage over about one-tenth of the LD50 of agrimoniin before the tumor cell inoculation, the mice almost completely rejected the tumor growth. Mice who were i. p. injected with lower doses at 4 days before the inoculation could not reject the tumor, and the tumor growth in 2 or 3 out of examined mice was observed until 2-4 weeks, but re gressed by 60 days after the inoculation. The i.v. (3 mg/kg) and p.o. (300 mg/kg) premedi cations could not completely reject the tumor, but caused tumor cell regression even at 14 days before the tumor cell inoculation. Agri moniin was effective also in the postmedica tion by each administration route (Table 3) . Some of the tumor-bearing mice died within a similar time as non-treated control mice, but the remaining mice showed inhibition of tumor growth.
Antitumor effect on MH134 and Meth-A solid type tumors: MH134-bearing C3H/He mice were given agrimoniin i.p. once a day aExcluding 60-day surviors . b[(T-C)/C]x100, T: mean survival days of treated mice, C: mean survival days of non-treated control mice.
Number of mice completely rejecting the tumor inoculation (rejectors) and resulted in the tumor regression (regressors) out of 6 examined mice in a group at 60 days after the tumor cell inoculation. for 12 days from day 1 to 12 or given the drug i.v. on days 7 and 10. Agrimoniin significantly suppressed the tumor growth and caused complete regression of the primary tumor in several mice by both types of administrations (Table 4) , but the mice still died due to lymphnodes and lung metastasis (data not shown). On Meth-A-bearing BALB/c mice, 3 and 10 mg/kg of agrimoniin markedly inhibited the tumor growth when it was i.p. administered once a day for 9 days from day 10 to 18.
In vitro cytotoxic activity against MM2 cells: MM2 cells were treated with agrimoniin for 2 hr in the absence or presence of fetal calf serum. Figure 2 shows the dose-response curves obtained after the culture for 2 days. Agrimoniin possessed potent direct cyto toxicity, and its IC50 was 2.6 ,ug/ml, but the effect was significantly decreased to an IC50 of 62.5 ,ug/ml by the addition of serum.
Influence on the number and cell popu lation of peripheral WBC: C3H/He mice were i. p. administered 10 mg/kg of agrimoniin. The total number of WBC significantly increased 4 to 10 days after the injection. In the cell population, the percentage of monocytes and eosinophils was markedly higher than that of the control. After 14 days, the total cell number and the percentage of eosinophils decreased to the control level, but the percentage of monocytes was still high (Fig. 3) .
Influence on PEC: At 4 days after the i.p.
injection, the number of PEC was sig nificantly increased in a dose-dependent manner (Fig. 4) Table 5) .
Induction of 3H-TdR uptake capacity of spleen cells: The observations on spleen after the i.p. injection with agrimoniin and OK-342 are shown in Fig. 5 . The spleen of the mice treated with this tannin enlarged and the weight increased.
The non-adherent spleen cells from the mice treated with both agents had the ability to take up 3H-TdR. Additionally, agrimoniin showed slight migration activity against spleen cells from non-treated mice ( Five C3H/He mice in a group were i.p. administered with agrimoniin (10 mg/kg); and after the indicated days, the number and population of WBC in peripheral blood were determined.
Data are the means of 5 mice. Neutrophils: rte, eosino phils: O, monocytes: M, lymphocytes: . evidence exists that each of them shows antitumor activity (4-9). Previously, we have indicated that the methanol extract from roots of Agrimonia pilosa LEDEB. showed potent antitumor activity against several transplan table rodent tumors and suggested that this plant contains some antitumor constituents (10) . We have demonstrated in the earlier paper (3) that agrimoniin, which is a tannin contained in large amounts in this plant, is the main antitumor active constituent of this plant. The results of the present study indicate that agrimoniin is effective on syngeneic rodent tumors. When agrimoniin was i.p. Agrimoniin was also effective on solid type tumors such as MH1 34 hepatoma and Meth-A fibrosarcoma.
In the observation of acute toxicity, agrimoniin caused stretching and writhing reactions by the i.p. injection and cyanosis and necrosis in the tail which was the i.v. injection site. These were considered inflam matory reactions based on the astringent actions of this tannin. The total number of peripheral WBC, the ratio of monocytes and eosinophils, and the spleen weight increased after the administration, and these responses of the host commonly occur after the adminis tration of inflammatics. PMLs also increased in the peritoneal fluid after the i.p. injection of this tannin, and this increase may be due to the local inflammation in the abdominal cavity. However, because the macrophage like cells and spleen cells from the mice treated with this compound showed cyto toxic activity and self growing ability, respec tively, the induction of these cells does not seem to be the result of a simple inflammatory reaction. A streptococcal preparation, OK 432, is known to have effective antitumor and immune modulatory activities (11) (12) (13) . This study also confirmed the host-mediated antitumor action of OK-432 through the induction of cytotoxic macrophages and self growing lymphocytes.
On the other hand, there are a few reports that the antitumor activity of Agrimonia pi/osa is attributed to only a direct action to tumor cells (14) . In this in vitro experiment, agrimoniin was highly cytotoxic to MM2 cells in the absence of calf serum, but the activity was markedly diminished by the addition of serum to the culture. Therefore, when this tannin was administered to the animal, it may bind to some entity (e.g., protein)
in the host, and its direct cyto toxicity to the tumor cells seems to be very weak. However, one may consider that this tannin binds to target cells such as tumor cells and enhances the antigen-antibody reaction as described for other tannins with an unknown mechanism.
Bacteria (11, 15, 16) and their components (17-19), some polysaccharides (20-22) and low molecular weight compounds such as levamizole (23) and bestatin (24) are well known as immunopotentiators. Agrimoniin presented in this study is a plant tannin. Its action mechanisms may be therefore thought to be different from the existing agents by its characteristic structure and pharmacological activities. Further detailed investigations for mechanisms of the antitumor activity are needed.
